Vitamin d boost tested to fight tough pancreatic cancer
NCT ID NCT04054362
Summary
This study tested if adding a drug called paricalcitol (a form of vitamin D) to standard chemotherapy could help control advanced pancreatic cancer that had spread. It involved 27 adults whose cancer had not been treated before and was no longer confined to the pancreas. The goal was to see if the vitamin D drug could slow tumor growth by changing the environment around the cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barts Health NHS Trust
London, London, Greater, EC1M 6BQ, United Kingdom
Conditions
Explore the condition pages connected to this study.